观察或治疗燃烧的多发性骨髓瘤? 随机对照研究的系统审查和元分析
Ioannis Ntanasis-Stathopoulos1, Charalampos Filippatos1, Panagiotis Malandrakis1
1Department of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Blood cancer journal
|May 26, 2025
概括
高风险燃烧多发性髓瘤 (sMM) 的早期治疗显著减少了进展和死亡. 早期干预虽然有益,但增加了严重不良事件的风险,需要密切监测.
科学领域:
- 血液学 血液学 血液学
- 临床瘤学临床瘤学
- 基于证据的医学基于证据的医学.
背景情况:
- 燃烧多发性骨髓瘤 (sMM) 通常通过观察来管理.
- 新出现的证据表明,早期治疗可能有利于高风险患者.
- 对于sMM的最佳管理策略仍在调查中.
研究的目的:
- 评估早期治疗与观察对患有燃烧多发性骨髓瘤的患者结局的影响.
- 通过系统性审查和元分析,综合随机临床试验 (RCT) 的证据.
主要方法:
- 遵循PRISMA指南的RCT的系统审查和元分析.
- 包括5项研究 (7篇文章),包括844名被诊断患有中级或高风险sMM的患者.
- 分析无进展生存,进展时间和整体生存,以及安全数据.
主要成果:
- 治疗显著降低了60%的疾病进展或死亡风险 (HR=0.40).
- 进展到症状多发性髓瘤的时间显著减少了58% (HR=0.42).
- 治疗组的总生存率显示死亡风险降低了45% (HR=0.55),严重不良事件增加了3.5倍.
结论:
- 选择高风险燃烧多发性骨髓瘤患者的早期治疗干预提供了显著的临床益处.
- 治疗有效地延缓了疾病的进展,并改善了生存结果.
- 管理需要仔细监测与治疗相关的毒性.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K


